Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18295)

• Formulation Name: Pyridostigmine 60 mg tablet
• Company: Cadila Healthcare; Zydus Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Pyridostigmine	(DM8HO1L)	Myasthenia gravis	8C6Y	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant